Forcyte Biotechnologies
YC W21Los Angeles, US · Founded 2017 · 5 employees · Inactive · 2 known investors
Forcyte Biotechnologies develops drug screening tools that measure cell contractility to identify therapeutic candidates for diseases driven by abnormal cellular force generation, such as asthma, fibrosis, and hypertension.
Founders & leadership· Y Combinator alumni (W21)
Ivan PushkarskyinFounder
Dino Di Carloin𝕏Founder
Investors · 2
In the news
- Forcyte Bio Secures New Funding From Y Combinator & Others, Bringing Total to >$5.7 Million - Forcyte Biotechnologies, Incforcytebio.com · 2022
- Forcyte Biotechnologies Secures Funding; Totals $5.7Mfinsmes.com · 2022
- Mechano-therapeutics Discovery Startup Forcyte Bio Secures New Funding From Y Combinator & Others, Bringing Total to >$5.7 Million, to Develop Drug Pipeline | Business Wirebusinesswire.com · 2022
- Forcyte Biotechnologies - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Forcyte Biotechnologies - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- UPDATE: Brentwood-Based Forcyte Biotechnologies Targets $2M Raise - Los Angeles Business Journallabusinessjournal.com · 2019
- Forcyte Biotechnologies Funding | Complete Analysis | Extruct AIextruct.ai